Skip to content

CTSO

Cytosorbents Corporation

NASDAQ · USHealthcareMedical - Devices
$0.38+5.58%

Price as of Jul 20, 2026

CTSO capital

Cytosorbents Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
8.64x
Net debt / equity
6.45x
Debt / assets
0.47x
Debt / EBITDA
-2.44x
Net debt / EBITDA
-1.82x

Liquidity & coverage

Current ratio
1.09x
Quick ratio
0.81x
Cash ratio
0.30x
Interest coverage
-11.65x
EBITDA / interest
-6.77x
Working capital
$1.5M

Cash & dividend

FCF / debt
-0.54x
Cash flow / debt
-0.53x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.